Latest Sales Growth News

Page 10 of 78
Oliver's Real Food swung to a statutory profit of $598k in FY2026, reversing a $2.91 million loss a year earlier, driven by store closures and cost discipline. Despite an 8% revenue drop, EBITDAI surged 36.8%, and the company kicked off FY27 with encouraging sales and earnings growth.
Victor Sage
Victor Sage
31 Aug 2026
Advance ZincTek posted an 11% rise in FY26 profit before tax to $2.247 million on 12.6% higher sales, driven by AI integration and US market strength. The company is set to enter residential battery manufacturing in FY27, leveraging its zinc oxide expertise.
Maxwell Dee
Maxwell Dee
31 Aug 2026
Clever Culture Systems expanded its pharmaceutical customer base to eight in FY26, placing 11 APAS Independence instruments and completing its product offering with a contact plate module. Despite a $2.24 million net loss, the company expects meaningful sales growth in FY27 backed by a robust pipeline and disciplined financial management.
Victor Sage
Victor Sage
31 Aug 2026
archTIS Limited’s FY2026 results reveal a 120% surge in sales revenue to $13.35 million, fueled by the Spirion acquisition, yet losses ballooned to $16.3 million reflecting higher operating costs and integration expenses.
Sophie Babbage
Sophie Babbage
31 Aug 2026
Novatti has swung to a positive EBITDA of $2.0 million in FY26, driven by strategic refocusing on its core Payments AU/NZ business despite a 40.7% revenue decline and loss of control over AUDC.
Claire Turing
Claire Turing
31 Aug 2026
Volt Group’s HY26 results showcase a surge in revenue and cashflow, powered by the 4D Delta acquisition and strong performances across its subsidiaries.
Victor Sage
Victor Sage
31 Aug 2026
Coventry Group delivered a 2.8% revenue rise in FY26, but underlying EBITDA fell 23.6% despite a strong second-half recovery. The Group achieved $10 million in cost savings and continues an ongoing strategic review with no immediate decisions.
Victor Sage
Victor Sage
31 Aug 2026
PT ANTAM (ASX:ATM) posted a 6% increase in net sales to Rp62.71 trillion in the first half of 2026, driven by steady gold, nickel, and bauxite sales. Profit after tax surged 34% to Rp6.91 trillion, supported by improved margins and foreign exchange gains.
Maxwell Dee
Maxwell Dee
31 Aug 2026
Michael Hill International delivered a landmark FY26 with record revenue of AU$655.7 million, a 57% jump in comparable EBIT, and reinstated dividends after a strategic turnaround.
Logan Eniac
Logan Eniac
31 Aug 2026
Michael Hill International reported a 1.9% revenue increase to $655.7 million in FY26, with comparable EBIT up 57% to $24 million and net profit soaring 376%. The company restored dividends and announced a Chair succession.
Logan Eniac
Logan Eniac
28 Aug 2026
OncoSil Medical lifted revenues 44% in FY26 to $1.68 million and trimmed losses by 28% to $10.86 million, buoyed by key regulatory approvals including FDA HDE and Australian TGA listings. The company is poised for commercial launches in the US and Australia, with strong clinical data underpinning its growth.
Ada Torres
Ada Torres
28 Aug 2026
Senetas Corporation reported a 4.7% rise in revenue to $20.2 million for FY2026, achieving a strong $4.4 million operating cash flow turnaround. The company advanced its AI governance platform while maintaining a robust sales pipeline and capital management strategy.
Sophie Babbage
Sophie Babbage
28 Aug 2026

Browse the archive

Full archive